Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vivos Inc. (RDGL)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0700+0.0036 (+5.34%)
At close: 03:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0664
Open0.0674
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0650 - 0.0707
52 Week Range0.0400 - 0.1195
Volume592,775
Avg. Volume315,356
Market Cap25.938M
Beta (5Y Monthly)1.60
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateOct 17, 2023 - Oct 23, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RDGL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VIVOS INC
    RVTY: Rating increased to a HOLDREVVITY INC has an Investment Rating of HOLD; a target price of $86.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
  • GlobeNewswire

    Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics

    Richland WA, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that it certified three additional clinics to offer Isopet® Precision Radionuclide Therapy (PRT). The three new clinics are The Myhre Equine Clinic, located in Rochester, New Hampshire, the Hopkinton Animal Hospital, located in Weare, New Hampshire and the Indian Creek Veterinary Hospital, located in Fort Wayne, Indiana. The Myhre Clinic will be focused on providing equine tumor therapy and

  • GlobeNewswire

    Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy

    Richland WA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that the company filed a utility patent application on a range of particles for precision radionuclide therapy as a follow-up to its provisional patent filed on 1/15/2022. This patent was filed in the USA and internationally via the Patent Cooperation Treaty, PCT. This includes Canada, the European Union, Japan, Australia, Brazil, China, India, South Korea, and the Russian Eurasian (Russia, Armenia

  • GlobeNewswire

    Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment

    Richland WA, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc announced today that they filed a provisional patent application on the system equipment to support precision radionuclide therapy. This includes the shipping containers, the shielded vial holder, the Peltier chiller, and the syringe shields. These device designs are integrated into our production standardization effort. They can be used for treating a range of tumor sizes from 0.5-gram human lymph nodes to half-p

Advertisement
Advertisement